Overview Pilot Study of ONO-5129 in Patients With Type 2 Diabetes Mellitus Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the efficacy, safety and pharmacokinetics of ONO-5129 in patients with type 2 diabetes mellitus. Phase: Phase 2 Details Lead Sponsor: Ono Pharma USA Inc